To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Commons Chamber - Thu 22 Oct 2020
Down Syndrome Awareness Month

"I thank my friend, the hon. Lady, for giving way. My family had a child with Down’s syndrome when I was young, and unfortunately he died very young. Does she agree that modern medicine has extended the lives of people with Down’s syndrome so much that they live as long …..."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Down Syndrome Awareness Month

Speech in Commons Chamber - Thu 22 Oct 2020
Down Syndrome Awareness Month

"When I was born in 1949, the life expectancy of someone with Down’s syndrome was 12 years. The life expectancy now, we hope, is somewhere in the 60s or 70s. I am sure the Minister will agree that we have to find a way to employ these people properly, and …..."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Down Syndrome Awareness Month

Speech in Commons Chamber - Thu 22 Oct 2020
Covid-19

"On that point, many of my constituents were frightened to go to hospital because they thought that they might get infected with covid. With that in mind—I am quite sure my right hon. Friend has thought of this—would it not be an idea to separate out hospitals, so that we …..."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Covid-19

Speech in Commons Chamber - Thu 22 Oct 2020
Covid-19

"To support the hon. Gentleman’s case, may I point out that if we could achieve herd immunity, we would not contract diseases like measles? We still get them, so herd immunity is impossible to achieve...."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Covid-19

Speech in Commons Chamber - Fri 16 Oct 2020
Botulinum Toxin and Cosmetic Fillers (Children) Bill

"This sounds awful. I am learning by sitting here and listening to this. Has anyone died as a result of these procedures? Apart from perhaps medically, has anyone been affected mentally and committed suicide? Have these procedures killed anyone?..."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Botulinum Toxin and Cosmetic Fillers (Children) Bill

Speech in Commons Chamber - Fri 16 Oct 2020
Botulinum Toxin and Cosmetic Fillers (Children) Bill

"Will my hon. Friend give way?..."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Botulinum Toxin and Cosmetic Fillers (Children) Bill

Speech in Commons Chamber - Fri 16 Oct 2020
Botulinum Toxin and Cosmetic Fillers (Children) Bill

"I am absolutely shocked that anyone who is not medically trained could wield a syringe, particularly on someone who is under 18. That is what I have learned this morning, and I suspect my hon. Friend agrees with me...."
Bob Stewart - View Speech

View all Bob Stewart (Con - Beckenham) contributions to the debate on: Botulinum Toxin and Cosmetic Fillers (Children) Bill

Written Question
Coronavirus: Disease Control
Wednesday 19th August 2020

Asked by: Bob Stewart (Conservative - Beckenham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the efficacy of health passports as part of its covid-19 recovery strategy.

Answered by Nadine Dorries

We first need to improve our understanding of the science around immunity in order to fully understand the potential of certification in the next phase of our response to this pandemic.

In order to gain answers to critical questions, the United Kingdom Government is conducting some of the biggest seroprevalence surveys in the world. This includes using lab-based tests to monitor the number of people that are presenting an antibody response and how this response changes over time. The UK Government is also closely monitoring the results from clinical trials of candidate COVID-19 vaccines to determine their efficacy and the immune response they generate.


Written Question
Coronavirus: Disease Control
Saturday 15th August 2020

Asked by: Bob Stewart (Conservative - Beckenham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the potential merits of introducing health passports as part of its (a) economic recovery strategy and (b) pre-second covid-19 wave contingency planning.

Answered by Nadine Dorries

We first need to improve our understanding of the science around immunity in order to fully understand the potential of certification to facilitate a return to the ‘new normal’ and as part of pre-second COVID-19 wave contingency planning.

In order to gain answers to critical questions, the United Kingdom Government is conducting some of the biggest seroprevalence surveys in the world. This includes using lab-based tests to monitor the number of people that are presenting an antibody response and how this response changes over time. The UK Government is also closely monitoring the results from clinical trials of candidate COVID-19 vaccines to determine their efficacy and the immune response they generate.


Written Question
Coronavirus: Disease Control
Saturday 15th August 2020

Asked by: Bob Stewart (Conservative - Beckenham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of introducing a documented immunity and vaccination status for covid-19 via a health passport on (a) the operation of the Government's air-bridge system and (b) the UK's economic resilience and efficiency as it recovers from the covid-19 outbreak.

Answered by Nadine Dorries

We first need to improve our understanding of the science around immunity in order to fully understand the potential of certification to facilitate a return to the ‘new normal’ – including to enable increased travel without the need to quarantine and increased economic activity.

In order to gain answers to critical questions, such as those relating to immunity to COVID-19 following infection with the virus, the United Kingdom Government is conducting some of the biggest seroprevalence surveys in the world. This includes using lab-based tests to monitor the number of people that are presenting an antibody response and how this response changes over time. The UK Government is also closely monitoring the results from clinical trials of candidate COVID-19 vaccines to determine their efficacy and the immune response they generate.